Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17497
Country/Region: Zambia
Year: 2016
Main Partner: University of Maryland
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $6,890,326 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $300,000
Care: TB/HIV (HVTB) $300,000
Care: Pediatric Care and Support (PDCS) $150,000
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $200,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,117,078
Treatment: Adult Treatment (HTXS) $3,723,248
Treatment: Pediatric Treatment (PDTX) $100,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 400
HTS_TST Age/sex: 1-9 2017 1,168
HTS_TST Age/sex: 10-14 Female 2017 221
HTS_TST Age/sex: 10-14 Male 2017 222
HTS_TST Age/sex: 15-19 Female 2017 1,196
HTS_TST Age/sex: 15-19 Male 2017 648
HTS_TST Age/sex: 20-24 Female 2017 4,256
HTS_TST Age/sex: 20-24 Male 2017 2,303
HTS_TST Age/sex: 25-49 Female 2017 5,575
HTS_TST Age/sex: 25-49 Male 2017 3,071
HTS_TST Age/sex: 50+ Female 2017 1,199
HTS_TST Age/sex: 50+ Male 2017 654
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,015
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,013
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 11,363
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 7,522
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 20,913
HTS_TST Service Delivery Point (Facility): Inpatient 2017 83
HTS_TST Service Delivery Point (Facility): Outpatient 2017 6,148
HTS_TST Service Delivery Point (Facility): Pediatric 2017 2,041
HTS_TST Service Delivery Point (Facility): PMTCT 2017 8,232
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,023
HTS_TST Service Delivery Point (Facility): VCT 2017 3,386
HTS_TST Sum of Age/Sex disaggregates 2017 19,345
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,028
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 18,885
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 20,913
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 24
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 22
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 125
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 69
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 427
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 237
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 554
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 294
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 119
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 69
HTS_TST_POS Test Result by Age: Positive: <1 2017 37
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 117
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 114
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 110
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,260
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 823
PMTCT_ART Already on ART at beginning of current pregnancy 2017 666
PMTCT_ART New on ART 2017 999
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 12,834
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 839
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 573
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 25
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 25
PMTCT_EID Sum of Infant Age disaggregates 2017 1,412
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 909
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 2,045
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 3,894
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 5,829
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 157
PMTCT_STAT By: Known positives at entry 2017 910
PMTCT_STAT By: Number of new positives identified 2017 608
PMTCT_STAT Number of new ANC and L&D clients 2017 12,834
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 12,834
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 57
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 167
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 298
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 377
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 13
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 27
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 88
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 225
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 260
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 6
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,518
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 945
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 2,149
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 3,941
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 5,642
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 157
PP_PREV Aggregated Age/sex: <15 Female 2017 1,693
PP_PREV Aggregated Age/sex: <15 Male 2017 1,693
PP_PREV Aggregated Age/sex: 15+ Female 2017 19,819
PP_PREV Aggregated Age/sex: 15+ Male 2017 10,669
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 33,874
PP_PREV Total number of people in the target population 2017 33,874
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 33
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 372
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 33
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 199
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 637
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 637
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,069
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 105
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,449
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 516
TB_SCREENDX Screen Result: Screened Positive for TB 2017 2,069
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 4,842
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,610
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 411
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 411
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 8,274
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 19
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 222
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 19
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 118
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 378
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 378
TX_CURR Age/Sex: <1 2017 462
TX_CURR Age/Sex: <1-9 2017 811
TX_CURR Age/Sex: 10-14 Female 2017 160
TX_CURR Age/Sex: 10-14 Male 2017 161
TX_CURR Age/Sex: 15-19 Female 2017 933
TX_CURR Age/Sex: 15-19 Male 2017 501
TX_CURR Age/Sex: 20-24 Female 2017 3,262
TX_CURR Age/Sex: 20-24 Male 2017 1,758
TX_CURR Age/Sex: 25-49 Female 2017 4,199
TX_CURR Age/Sex: 25-49 Male 2017 2,261
TX_CURR Age/Sex: 50+ Female 2017 930
TX_CURR Age/Sex: 50+ Male 2017 501
TX_CURR Aggregated Age/Sex: <15 Female 2017 801
TX_CURR Aggregated Age/Sex: <15 Male 2017 798
TX_CURR Aggregated Age/Sex: 15+ Female 2017 8,609
TX_CURR Aggregated Age/Sex: 15+ Male 2017 5,731
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 15,939
TX_CURR Sum of age/sex disaggregates 2017 1,434
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,599
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 14,340
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 15,939
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 66
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 64
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 773
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 459
TX_NEW By Age/Sex: <1 2017 31
TX_NEW By Age/Sex: 1-9 2017 60
TX_NEW By Age/Sex: 10-14 Female 2017 16
TX_NEW By Age/Sex: 10-14 Male 2017 15
TX_NEW By Age/Sex: 15-19 Female 2017 73
TX_NEW By Age/Sex: 15-19 Male 2017 38
TX_NEW By Age/Sex: 20-24 Female 2017 260
TX_NEW By Age/Sex: 20-24 Male 2017 144
TX_NEW By Age/Sex: 25-49 Female 2017 423
TX_NEW By Age/Sex: 25-49 Male 2017 196
TX_NEW By Age/Sex: 50+ Female 2017 67
TX_NEW By Age/Sex: 50+ Male 2017 39
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,362
TX_NEW Sum of Age/Sex disaggregates 2017 1,271
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,362
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 3,687
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 3,679
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 185
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 185
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,152
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,157
TX_PVLS Numerator: Indication: Routine 2017 3,312
TX_PVLS Numerator: Indication: Targeted 2017 367
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 185
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 185
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,158
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,159
TX_PVLS_den Denominator: Indication: Routine 2017 3,321
TX_PVLS_den Denominator: Indication: Targeted 2017 366
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 47
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 105
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 51
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 51
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 690
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 228
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 695
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 570
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 111
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 127
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 122
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,491
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 819
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,555
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,595
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 46
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 106
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 51
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 51
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 690
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 228
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 695
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 570
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 111
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 127
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 122
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,491
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 815